P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Detalles Bibliográficos
Autores principales: Wong, R., Fishman, J., Wilson, K., Yeh, M., Hakimi, Z., Yee, C., Huynh, L., Duh, M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429559/
http://dx.doi.org/10.1097/01.HS9.0000846244.47350.40
_version_ 1784779482960232448
author Wong, R.
Fishman, J.
Wilson, K.
Yeh, M.
Hakimi, Z.
Yee, C.
Huynh, L.
Duh, M. S.
author_facet Wong, R.
Fishman, J.
Wilson, K.
Yeh, M.
Hakimi, Z.
Yee, C.
Huynh, L.
Duh, M. S.
author_sort Wong, R.
collection PubMed
description
format Online
Article
Text
id pubmed-9429559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94295592022-08-31 P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA Wong, R. Fishman, J. Wilson, K. Yeh, M. Hakimi, Z. Yee, C. Huynh, L. Duh, M. S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429559/ http://dx.doi.org/10.1097/01.HS9.0000846244.47350.40 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Wong, R.
Fishman, J.
Wilson, K.
Yeh, M.
Hakimi, Z.
Yee, C.
Huynh, L.
Duh, M. S.
P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_full P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_fullStr P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_full_unstemmed P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_short P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
title_sort p840: a matching-adjusted indirect comparison of the efficacy of pegcetacoplan using prince trial data versus ravulizumab and eculizumab in complement-naïve patients with paroxysmal nocturnal hemoglobinuria
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429559/
http://dx.doi.org/10.1097/01.HS9.0000846244.47350.40
work_keys_str_mv AT wongr p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria
AT fishmanj p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria
AT wilsonk p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria
AT yehm p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria
AT hakimiz p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria
AT yeec p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria
AT huynhl p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria
AT duhms p840amatchingadjustedindirectcomparisonoftheefficacyofpegcetacoplanusingprincetrialdataversusravulizumabandeculizumabincomplementnaivepatientswithparoxysmalnocturnalhemoglobinuria

Ejemplares similares